Influenza A virus H5N1 vaccine (Medicago)

N/A

Report date: 2022/11/25 17:25:19

Base Information

Drug NameInfluenza A virus H5N1 vaccine (Medicago)

Drug Alias Name甲型流感病毒H5N1疫苗 - MedicagoPandemic flu vaccineH5N1 avian influenza virus-like particle (VLP) vaccinePlant-made H5 VLP influenza vaccinePlant-derived influenza vaccines +[8]

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiratory Tract DiseasesRNA Virus InfectionsVirus Diseases +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMedicago Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMedicago Inc

Active IndicationsN/A

Inactive IndicationsRespiratory Tract DiseasesRNA Virus InfectionsVirus Diseases +[4]

Other Information

ATC CodeN/A